当前位置: 首页 > 期刊 > 《中国现代医生》 > 2021年第15期
编号:669926
胸腺肽联合依替米星治疗肺结核的有效性分析
http://www.100md.com 2021年9月16日 中国现代医生 2021年第15期
     张雪

    [关键词] 胸腺肽;依替米星;肺结核;不良反应

    [中图分类号] R521? ? ? ? ? [文献标识码] B? ? ? ? ? [文章编号] 1673-9701(2021)15-0077-04

    Effectiveness analysis of thymosin combined with etimicin in the treatment of tuberculosis

    ZHANG Xue

    Tuberculosis Ward Ⅲ, Shenyang Tenth People′s Hospital, Shenyang? ?110000, China

    [Abstract] Objective To observe the effectiveness of thymosin combined with etimicin in the treatment of tuberculosis. Methods A total of 104 tuberculosis patients diagnosed and treated from May 2018 to May 2019 were selected and they were divided into the control group and the study group using a random number table method, with 52 cases in each group. The control group was treated with conventional treatment, and the study group was treated with thymosin and etimicin. The therapeutic efficacy and the rate of adverse reactions of two groups were compared. Changes and differences of related inflammatory factor indexes ......

您现在查看是摘要页,全文长 9915 字符